What are analysts Suggestions on Assured Guaranty Ltd.(NYSE:AGO): Dr. Reddy’s Laboratories Ltd(NYSE:RDY)

0
2

Assured Guaranty Ltd. (AGO) will report its next earnings on Feb 06 AMC. The company reported the earnings of $0.79/Share in the last quarter where the estimated EPS by analysts was $0.76/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 3.9%.

Many analysts are providing their Estimated Earnings analysis for Assured Guaranty Ltd. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $0.78/share. These analysts have also projected a Low Estimate of $0.72/share and a High Estimate of $0.87/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Assured Guaranty Ltd. as 204 Million. According to these analysts, the Low Revenue Estimate for Assured Guaranty Ltd. is 202 Million and the High Revenue Estimate is 206 Million. The company had Year Ago Sales of 214 Million.

Some buy side analysts are also providing their Analysis on Assured Guaranty Ltd., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.63 and Average Volume (3 months) is 524.72 million. The company’s P/E (price to earnings) ratio is 14.5 and Forward P/E ratio of 14.42.

The company shows its Return on Assets (ROA) value of 2.6%. The Return on Equity (ROE) value stands at 5.3%. While it’s Return on Investment (ROI) value is 7.8%.

While looking at the Stock’s Performance, Assured Guaranty Ltd. currently shows a Weekly Performance of 2.65%, where Monthly Performance is -2.03%, Quarterly performance is 5.55%, 6 Months performance is 12.8% and yearly performance percentage is 24.58%. Year to Date performance value (YTD perf) value is 0.51%. The Stock currently has a Weekly Volatility of 1.11% and Monthly Volatility of 1.15%.

Dr. Reddy’s Laboratories Ltd (RDY) will report its next earnings on Jan 27 BMO. The company reported the earnings of $0.93/Share in the last quarter where the estimated EPS by analysts was $0.49/share. The difference between the expected and actual EPS was $0.44/share, which represents an Earnings surprise of 89.8%.

Many analysts are providing their Estimated Earnings analysis for Dr. Reddy’s Laboratories Ltd and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $0.51/share. These analysts have also projected a Low Estimate of $0.51/share and a High Estimate of $0.51/share.

Some buy side analysts are also providing their Analysis on Dr. Reddy’s Laboratories Ltd, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.42 and Average Volume (3 months) is 172.39 million. The company’s P/E (price to earnings) ratio is 18.77 and Forward P/E ratio of 24.

The company shows its Return on Assets (ROA) value of 11.7%. The Return on Equity (ROE) value stands at 18.6%. While it’s Return on Investment (ROI) value is 9.7%.

While looking at the Stock’s Performance, Dr. Reddy’s Laboratories Ltd currently shows a Weekly Performance of 3.39%, where Monthly Performance is 4.87%, Quarterly performance is 11.98%, 6 Months performance is 12.54% and yearly performance percentage is 13.81%. Year to Date performance value (YTD perf) value is 4.61%. The Stock currently has a Weekly Volatility of 1.67% and Monthly Volatility of 1.35%.

SHARE